Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs - ACR Meeting Abstracts
Por um escritor misterioso
Descrição
Background/Purpose: Although Ankylosing Spondylitis Disease Activity Score (ASDAS) low disease activity (LDA) is a common treatment target for disease control when managing AS, real-world research describing ASDAS LDA achievement among patients treated with biologic DMARDs (bDMARD) is limited. The aim of this study was to describe disease activity and patient-reported outcome measures (PROMs) among patients […]
Safety Profile, Axial Spondyloarthritis
Impact of Achieving Minimal Disease Activity on Patient-Reported
PDF) Response to lower dose TNF inhibitors in axial
Full article: Effectiveness of bDMARDs in ankylosing spondylitis
Dual neutralisation of interleukin-17A and interleukin-17F with
Performance of 3 Composite Measures for Disease Activity in
PDF) Multi-biomarker disease activity score as a predictor of
PDF) Achieving minimal disease activity in psoriatic arthritis
PDF) AB0002 Sirt-1 Activity in PBMC from Patients with
Frontiers Residual Pain in the Context of Selecting and
JPM, Free Full-Text
Efficacy of a tight-control and treat-to-target strategy in axial
de
por adulto (o preço varia de acordo com o tamanho do grupo)
